4007787550
|
 |
||||||||||||||
| 货号 | 品名 | 规格 | 包装 | 单价 | 货期 | 库存 |
| JD200512091500 | 利妥昔单抗 | 99.85% | 5mg | 11200元 | 咨询客服 | 3天 |
| JD200512091432 | 利妥昔单抗 | 99.85% | 1mg | 5600元 | 咨询客服 | 3天 |
| 性状： | Rituximab是用于治疗某些自身免疫疾病和癌症类型的抗CD20嵌合单克隆抗体。 |
| 质量标准： | Description Rituximab is an anti-CD20 chimeric monoclonal antibody used to treat certain autoimmune diseases and types of cancer. Molecular Weight 144544.44 Shipping Shipping with dry ice. Storage Please store the product under the recommended conditions in the Certificate of Analysis. References [1]. Kamburova EG, et al. In vitro effects of rituximab on the proliferation, activation and differentiation of human B cells. Am J Transplant. 2012 Feb;12(2):341-50. [2]. Manches O, et al. In vitro mechanisms of action of rituximab on primary non-Hodgkin lymphomas. Blood. 2003 Feb 1;101(3):949-54. [3]. Byrd JC, et al. The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction. Blood. 2002 Feb 1;99(3):1038-43. |
